Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp IGXT


Primary Symbol: T.IGX

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Reports Fourth Quarter and Full-Year 2020 Financial Results

GlobeNewswire March 25, 2021

IntelGenx to Report Fourth Quarter and Full-Year 2020 Financial Results on March 25, 2021 - Conference Call to Follow

GlobeNewswire March 18, 2021

IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation

GlobeNewswire March 15, 2021

Kane Biotech Announces New Chairman

GlobeNewswire February 24, 2021

IntelGenx Receives USPTO Notice of Allowance for its Novel DisinteQ(TM)-Based Disintegrating THC Oral Film

GlobeNewswire February 17, 2021

IntelGenx Files Provisional U.S. Patent Application for Novel VetaFilm(TM) High Loading Oral Film Platform

GlobeNewswire February 8, 2021

IntelGenx Appoints Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel

GlobeNewswire January 12, 2021

IntelGenx Receives First Purchase Order For CBD Filmstrips From Heritage Cannabis

GlobeNewswire January 7, 2021

IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures

GlobeNewswire January 6, 2021

IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures

GlobeNewswire December 8, 2020

IntelGenx Grants Stock Options

GlobeNewswire November 23, 2020

IntelGenx Reports Third Quarter 2020 Financial Results

GlobeNewswire November 12, 2020

IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films

GlobeNewswire November 11, 2020

IntelGenx Announces Publication of a Study Evaluating Montelukast's Effect on Neurological Aging

GlobeNewswire November 9, 2020

IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 - Conference Call to Follow

GlobeNewswire November 5, 2020

IntelGenx Signs Letter of Intent with Heritage Cannabis for Long-Term Cannabis Filmstrip Supply Agreement

GlobeNewswire October 29, 2020

IntelGenx Announces Second Tranche Closing of Private Placement

GlobeNewswire October 23, 2020

IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

GlobeNewswire October 21, 2020

IntelGenx Closes U.S.$1.2 Million Private Placement Financing

GlobeNewswire October 15, 2020

IntelGenx and Exeltis Healthcare S.L. Expand RIZAPORT® Commercialization Agreement to Include the European Union

GlobeNewswire August 27, 2020